Propylthiouracil

What is Propylthiouracil

Propylthiouracil (PTU) is an oral antithyroid agent. Propylthiouracil, a thio-urea derivative, differs both chemically and structurally from methimazole, another antithyroid agent.

Antithyroid agents are indicated for various hyperthyroid conditions including maintenance of a euthyroid state in patients with Graves’ disease or toxic multinodular goiter.

Due to a risk for hepatotoxicity, PTU should be reserved for patients who can not tolerate methimazole and in whom radioiodine therapy or surgery are not appropriate treatments for the management of hyperthyroidism.

An exception to this restriction is that PTU is generally the preferred agent in the first trimester of pregnancy, due to the known teratogenic effects of methimazole.

Propylthiouracil was approved by the FDA in 1947.

Indications

  • Graves’ disease
  • hyperthyroidism
  • thyrotoxicosis

For the treatment of hyperthyroidism (due to Graves’ disease or toxic multinodular goiter) or to ameliorate symptoms of hyperthyroidism prior to thyroidectomy or radioactive iodine therapy

Side Effects

  1. agranulocytosis
  2. alopecia
  3. anorexia
  4. aplastic anemia
  5. arthralgia
  6. bleeding
  7. drowsiness
  8. dysgeusia
  9. edema
  10. elevated hepatic enzymes
  11. erythema nodosum
  12. exfoliative dermatitis
  13. fever
  14. glomerulonephritis
  15. headache
  16. hepatic failure
  17. hepatic necrosis
  18. hepatitis
  19. hepatotoxicity
  20. hypoprothrombinemia
  21. hypothyroidism
  22. interstitial nephritis
  23. ischemic colitis
  24. jaundice
  25. leukopenia
  26. lupus-like symptoms
  27. lymphadenopathy
  28. malaise
  29. myalgia
  30. nausea
  31. neuritis
  32. pancytopenia
  33. paresthesias
  34. periarteritis
  35. peripheral neuropathy
  36. pneumonitis
  37. pruritus
  38. rash
  39. renal failure (unspecified)
  40. skin hyperpigmentation
  41. splenomegaly
  42. Stevens-Johnson syndrome
  43. teratogenesis
  44. thrombocytopenia
  45. toxic epidermal necrolysis
  46. urticaria
  47. vasculitis
  48. vertigo
  49. vomiting

Monitoring Parameters

  • CBC with differential
  • LFTs
  • thyroid function tests (TFTs)

Contraindications

  • agranulocytosis
  • bone marrow suppression
  • breast-feeding
  • children
  • fever
  • hepatic disease
  • hepatitis
  • hepatotoxicity
  • infants
  • jaundice
  • neonates
  • neutropenia
  • pregnancy
  • vasculitis

Interactions

  • Acebutolol
  • Amiodarone
  • Atenolol
  • Atenolol; Chlorthalidone
  • Bendroflumethiazide; Nadolol
  • Beta-blockers
  • Betaxolol
  • Bisoprolol
  • Bisoprolol; Hydrochlorothiazide, HCTZ
  • Brimonidine; Timolol
  • Carteolol
  • Carvedilol
  • Deferiprone
  • Digoxin
  • Dorzolamide; Timolol
  • Esmolol
  • Hydrochlorothiazide, HCTZ; Metoprolol
  • Hydrochlorothiazide, HCTZ; Propranolol
  • Iodine; Potassium Iodide, KI
  • Iodoquinol
  • Labetalol
  • Levobetaxolol
  • Levobunolol
  • Macimorelin
  • Methylprednisolone
  • Metoprolol
  • Nadolol
  • Nebivolol
  • Nebivolol; Valsartan
  • Penbutolol
  • Pexidartinib
  • Pindolol
  • Potassium Iodide, KI
  • Prednisone
  • Propranolol
  • Riluzole
  • Sodium Iodide
  • Sotalol
  • Theophylline, Aminophylline
  • Thyroid hormones
  • Timolol
  • Warfarin
15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856